REATA PHARMACEUTICALS INC Annual Operating Lease, Payments in USD from 2019 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Reata Pharmaceuticals Inc quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2022.
  • Reata Pharmaceuticals Inc Operating Lease, Payments for the quarter ending March 31, 2023 was $3.9M, a 388% increase year-over-year.
  • Reata Pharmaceuticals Inc annual Operating Lease, Payments for 2022 was $9.5M, a 197% increase from 2021.
  • Reata Pharmaceuticals Inc annual Operating Lease, Payments for 2021 was $3.2M.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $9.5M +$6.3M +197% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-24
2021 $3.2M Jan 1, 2021 Dec 31, 2021 10-K 2022-02-28
2019 $2.4M Jan 1, 2019 Dec 31, 2019 10-K 2020-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.